N/A
N=338
A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection
Urinary Tract Infections · Bladder, Neurogenic
Bottom Line
View on ClinicalTrials.gov: NCT00591240 ↗Enrolled (actual)
338
Serious AEs
—
Results posted
Jun 2016
Primary outcome: Primary: Clinical Validation of Biosensor Assays Used for Pathogen Identification and Antimicrobial Susceptibility Testing in Patients at Risk of Urinary Tract Infections. — 89; 92; 100; 97 percentage of urine specimen
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Jun 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Clinical Validation of Biosensor Assays Used for Pathogen Identification and Antimicrobial Susceptibility Testing in Patients at Risk of Urinary Tract Infections. |
89; 92; 100; 97; 76; 81 | — |
Summary
The purpose of this proposal is clinical validation of an electrochemical biochip for rapid pathogen identification and antibiotic susceptibility determination.
Eligibility Criteria
Inclusion Criteria
- Patients suspected or at risk for complicated urinary tract infections
Exclusion Criteria
- Gross contamination of urine samples at the time of collection
Data sourced from ClinicalTrials.gov (NCT00591240). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.